Bristol-Myers Squibb Company Ce
CELG-RI · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $2,195 | $1,313 | $2,456 | $76 |
| Dep. & Amort. | $1,011 | $1,011 | $1,012 | $1,880 |
| Deferred Tax | -$359 | -$437 | $223 | -$791 |
| Stock-Based Comp. | $139 | $137 | $144 | $120 |
| Change in WC | $3,055 | $15 | -$1,871 | $1,276 |
| Other Non-Cash | $270 | $1,878 | -$10 | $1,878 |
| Operating Cash Flow | $6,311 | $3,917 | $1,954 | $4,439 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$320 | -$361 | -$260 | -$378 |
| Net Acquisitions | -$2,387 | -$285 | -$78 | $286 |
| Inv. Purchases | -$665 | -$621 | -$636 | -$371 |
| Inv. Sales/Matur. | $878 | $524 | $232 | $267 |
| Other Inv. Act. | $792 | $270 | $243 | $0 |
| Investing Cash Flow | -$1,702 | -$473 | -$499 | -$196 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$224 | -$585 | $368 | -$405 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | -$1,263 | -$1,262 | -$1,258 | -$1,218 |
| Other Fin. Act. | -$3 | $11 | -$103 | -$19 |
| Financing Cash Flow | -$1,490 | -$1,836 | -$993 | -$1,642 |
| Forex Effect | -$4 | $128 | $66 | -$147 |
| Net Chg. in Cash | $3,115 | $1,736 | $528 | $2,454 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $12,611 | $10,875 | $10,347 | $7,893 |
| End Cash | $15,726 | $12,611 | $10,875 | $10,347 |
| Free Cash Flow | $5,991 | $3,556 | $1,694 | $4,061 |